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Abstract: Chirasil-β-Dex containing an undecamethylene spacer (C11-Chirasil-Dex) was synthesized and used as chiral 
stationary phase (CSP) in enantioselective gas chromatography (GC). The versatility of the new stationary phase in the 
simultaneous enantiomeric separation of a set of N-alkylated barbiturates is demonstrated.
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Introduction
Barbiturates were ﬁ  rst introduced for medical use in the early 1900s. More than 2,500 barbiturates have 
been synthesized, and at the height of their popularity, about 50 were marketed for human use [1]. Yet, 
about a dozen are in medical use. Barbiturates produce a wide spectrum of central nervous system 
depression ranging from mild sedation to coma. By virtue of this, they have been used as sedatives, 
hypnotics, anesthetics, and anticonvulsants [2]. The primary differences among many of these products 
are how fast they produce an effect and how long those effects last. Barbiturates are classiﬁ  ed as ultra-
short, short, intermediate, and long-acting. Their enantiomers should be of particular interest. For 
example, Knabe et al demonstrated that the narcotic effects of the enantiomers of N-alkylated barbitu-
rates differ markedly [3, 4]. In some instances one of the enantiomers even displays convulsive properties. 
The enantiomers also showed different pharmacokinetic properties.
A number of synthetic methodologies have been developed to access to enantiomerically pure 
barbiturates [5, 6]. The ways in which efﬁ  ciency and practicality of these procedures are deﬁ  ned is 
depending on a large number of factors such as scale, reagent costs, time allotted and required. Most 
importantly, the requirement of suitable equipments and reliable methods for the determination of the 
enantiomeric excesses (ee) of the resulting products. The development of accurate non-chiroptic methods 
for the determination of enantiomeric purity has been critical for the development of enantioselective 
catalysis. Thus, a prerequisite in asymmetric synthesis is a precise and reliable assessment of the enan-
tiomeric purity of the resulting products [7, 8]. Among these methods are: polarimetric methods, gas 
chromatographic methods, liquid chromatographic methods and NMR spectroscopy. The modern and 
most sensitive methods used in the determination of enantiomeric purity of chiral drugs, allowing a 
detection as little as 0.1% of one enantiomer in the presence of another, are chiral GC and HPLC meth-
ods. For an efﬁ  cient monitoring of the reaction progress, enantioselective gas chromatography (GC) 
was the method of choice for the simultaneous resolution of barbiturates enantiomers.
Although a large number of chiral stationary phases (CSPs) have been developed [9–15], the choice 
of an appropriate column is still difﬁ  cult to achieve. Modiﬁ  ed cyclodextrins (CDs) have been widely 
used as chiral stationary phases for GC separation of racemic chiral compounds. These CD derivatives 
are dissolved in polysiloxane phases and are used for preparing efﬁ  cient capillary columns. Chirasil-
β-Dex, a polysiloxane-anchored permethylated β-cyclodextrin with 3, 5 and 8 spacer have been success-
fully used as CSP in GC [9]. In this contribution, we report on the investigation of Chirasil-β-Dex with 
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a new 11-spacer as CSP for the gas chromatographic 
enantiomers separation of a set of N-alkylated bar-
biturates.
Experimental
Preparation of Chirasil-Dex by hydro-
silylation [7]
In nitrogen atmosphere, 0.56 g (appr. 0.19 mmol) 
dimethylpolysiloxane containing 9.3% CH3-Si-
H groups and 0.37 g (0.23 mmol) of permethyl-
ated 11-undec-1-enyl β-cyclodextrin, dried in 
vacuo at 40 °C over P4O10 for 72 hrs, and 100 
ml of dry toluene were placed into 100 ml three-
necked, round-bottomed ﬂ  ask equipped with a 
nitrogen inlet and reﬂ  ux condenser ﬁ  tted with a 
mercury valve. To the reﬂ  uxing reaction mixture 
were added a few droplets of a semi-concentrated 
solution of the catalyst H2PtCl6 in anhydrous 
THF at intervals of 150 min each. After 48 hrs 
reﬂ  ux at 115 °C, the solvent was evaporated in 
vacuo with rotary evaporator yielding 1.35 g 
product [7].
Materials
All N-alkylated barbiturates: 5-ethyl-1-methyl-
5-n-propyl barbituric acid (1), 1-methyl-5-
(2-propyl)-5-(n-propyl) barbituric acid 
(2), 1, 5-dimethyl-5-ethyl barbituric acid (3), 1,5-
dimethyl-5-phenyl barbituric acid (4) also known 
as methylheptobarbital or methyleudan, 5-cyclo-
hexyl-5-ethyl-1-methyl-barbituric acid (5), 5-(1-
cyclopenten-1-yl)-5-ethyl-1-methyl barbituric acid 
(6), 1-methyl-5-phenyl-5-propyl barbituric acid 
(7), 5-(1-cyclohexen-1-yl)-1,5-dimethyl barbituric 
acid (8), 1-methyl-5-butyl-5-phenyl barbituric acid 
(9), 1-ethyl-5-methyl-5-piperidyl barbituric acid 
(10), 5-(1-cyclohexen-1-yl)-1-ethyl-5-methyl bar-
bituric acid (11), 5-(1-cyclohexen-1-yl)-5-methyl-
1-propyl barbituric acid (12) were given as a gift 




A gas chromatograph (Agilent Technologies, 
Waldbronn, Germany) equipped with a flame 
ionization detector (FID) was used. The chiral 
stationary phase chirasil-β-cyclodextrin with the 
new 11-spacer was coated on a non-deactivated coated 
on 19 m × 0.25 mm fused silica capillary column 
(0.25 µm ﬁ  lm thickness) according to the literature 
procedure [7]. The analytical conditions were: Injector 
temperature, 250 °C; FID temperature, 250 °C; oven 
temperature is varying according to the analyte itself. 
Hydrogen was used as the carrier gas (40 KPa column 
head pressure).
Results and discussion
Chirasil-β-Dex with a new 11-spacer (C11-Chira-
sil-Dex) was synthesized and characterized by 
1H, 
13C-NMR and IR spectroscopy conﬁ  rming the 
chemical link of the cyclodextrin moiety 
to the polysiloxane backbone [9]. Schurig and 
Combret et al reported that this non-regioselective 
Chirasil-Dex columns formulated as O-6, but now 
revised as a mixture of O-2-and O-6-Chirasil-Dex 













































































Figure 1. The structure of the synthesized permethylated 
β-cyclodextrin with a new C11-spacer (C11-Chirasil-Dex) bonded 
to a polysiloxane backbone and used as chiral stationary phase 
in GC.77
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This new chiral stationary phase was previously 
used to determine the enantiomeric excesses of 
secondary alcohols and their corresponding esters 
resulting from the lipase-catalyzed enantioselective 
transesterification in organic solvents and the 
intermolecular cyclopropanation of oleﬁ  ns cata-
lyzed by rhodium (II) catalyst.
The enantioselective resolution of racemic bar-
biturates using GC and liquid chromatography using 
different chiral stationary phase has been previously 
reported [17, 18]. In our effort to discover new 
applications for the newly developed Chirasil β-dex 
with 11 spacer (C11-Chirasil dex), the enantioselec-
tive resolution of a set of N-alkylated barbiturates 
was investigated (cf Fig. 2).
Among all racemic barbiturates investigated in 
this study, enantiomers of 1–6 and 10 were base-
line resolved, however, 7 was partially separated 
(cf Fig. 3–5).
On the other hand, 8, 9, 11 and 12 have never 
been separated using different temperature pro-
gram. A cyclohexen-1-yl group at C5 is in common 
in the structures of the unresolved racemates of 8, 
11 and 12 while a phenyl group associated with an 
n-butyl group was at C5 in the unresolved 9 and a 
























Figure 3. Enantioselective gas chromatographic separation of 
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Figure 4. Enantioselective gas chromatographic separation of 
N-alkylated barbiturates (4, 5 and 6). Oven tempereature was 
180 °C isothermal.
Figure 5. Enantioselective gas chromatographic separation of 
N-alkylated barbiturates (7 and 10). An oven tempereature program 
was applied:150 °C for 30 min followed a temperature increase of 
30 °C/min to 180 °C for 7 and 150 °C for 13 min followed a tem-
perature increase of 30 °C/min to 180 °C for 10.
phenyl group associated with an n-propyl group 
was at C5 in the partially separated 7. It concluded 
to us that the chiral recognition ability of the chiral 
stationary phase towards the analyzed barbiturates 
is depending to a large extent on the type of sub-
stituent at C5 in barbiturates structures. For 
example, those who process an n-alkyl group (up 
to n = 3) or/and a phenyl group at C5 were easily 
recognized by the chiral stationary phase and hence 
being resolved, while those having a cyclohxen-
1-yl group at C5 are not recognized and unresolved. 
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separation factor (α) and the resolution (Rs) are 
shown in Table 1. A chromatogram showing the 
enantioselective resolution of all investigated bar-
biturates in one run is demonstrated in Figure 6.
Conclusion
The utility of polysiloxane-anchored permethylated 
β-cyclodextrins (Chirasil-β-dex) as CSP in GC was 
demonstrated in the enantioselective separation of 
a set of N-alkylated barbiturates. The developed 
GC method is useful for the reaction monitoring 
involving the synthesis of barbiturates.
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